dusts have a role in the aetiology of cryptogenic fibrosing alveolitis. Several metal dusts have been implicated as causes of pulmonary fibrosis,'4 but whether in our patients metal and wood dusts were true fibrotic agents or markers of exposure to other fibrogens is not clear. For example, workers exposed to metal dust are often also exposed to grinding or lubricating materials, and joiners exposed to wood dust may also work with insulation or roofing materials containing asbestos. In relation to exposure to cattle, cryptogenic fibrosing alveolitis in a dairy worker has previously been attributed to occupational exposure to hydrogen peroxide.'5 Clearly, the extent of confounding by exposure to other agents needs to be explored, but the necessary detail is not available in the present study. Our finding that patients with cryptogenic fibrosing alveolitis had had a higher exposure to domestic wood fires adds support to a suggestion that wood smoke may be a cause of the disease.'6 Cigarette smoke, however, had no appreciable effect in the present study despite an apparent protective effect against lung fibrosis due to extrinsic allergic alveolitis or sarcoidosis. '7 18 The relevance of the increased reporting of allergic symptoms by our patients is not clear as shortness of breath on exposure to allergens may be a non-specific symptom and recall bias may also have contributed. Further investigation of this is therefore indicated. Future studies should also investigate whether disease associated with inhalation of dust differs in terms of histological findings or clinical progress from the classic rapidly progressing form of the disease as cryptogenic fibrosing alveolitis might be a stereotyped end organ response to many different aetiological factors. The present evidence associating the disease with potentially avoidable exposure to environmental agents, however, raises the possibility that it may at least to some extent be preventable.
We thank Dr Jim Pearson for his advice on computing and statistics, Mrs Mary Stevenson for entering and verifying the data, and Mrs Bernadette Maughan and others of the family practitioner committee for selecting the controls.
Copies of the questionnaire are available on request. Cryptogenic fibrosing alveolitis, fibrosing alveolitis, and fibrosis not mentioned 17 evident in the older age groups in both sexes (fig 2) . Complete data on age, sex, and region of residence were available for 4411 of the 4433 people who died of the disease from 1979 to 1987. The odds of death were higher in men by a ratio of 2-24 (95% confidence interval 2-11 to 2 38) and increased progressively with age; mortality in those aged ¢v75 was roughly double that in those aged 65-74 and eight times that in those aged 45-54 (table I). The regional number of deaths varied between 185 in East Anglia and 1442 in the south east; after adjustment for age and sex there were small but significant residual differences in mortality between the regions, the odds ratios between the highest and lowest being 1 25 (table I, fig 3) .
Data on manual or non-manual occupation were available for 1578 men and 242 women aged 15-74; social class codes were not provided for people who died aged over 74. In men, after allowance for age, social class had virtually no independent effect on mortality (odds ratio 1-02 for manual relative to nonmanual occupation) and a negligible effect on odds ratios for the region of residence.
VALIDITY OF DEATH CERTIFICATION
Case records were available for 23 of the 25 patients coded as having died of cryptogenic fibrosing alveolitis whose deaths had been registered in Nottingham. According to the criteria that we used, 19 patients had had definite or possible cryptogenic fibrosing alveolitis and only three clearly had not had the disease (table II) . Nine ofthose coded as having died ofpost-inflammatory pulmonary fibrosis had had definite or possible cryptogenic fibrosing alveolitis.
Death certificates were traced for 45 of the 48 patients with cryptogenic fibrosing alveolitis in Nottingham whom we knew from clinical records had died during 1985-9. The disease was mentioned in only 25 certificates and given as the underlying cause of death in 17 (table III) .
Discussion
Our study shows that from 1979 to 1988 the number of deaths reported to be due to cryptogenic fibrosing alveolitis increased substantially and that the disease is an important contributor to the overall mortality from respiratory diseases. These findings raise the questions of whether this increase in mortality is a true increase and what the underlying cause of the disease might be.
To What other factors might explain the rise in reported mortality? Changes in diagnostic practice may be a factor. For instance, some of the increase in mortality in the elderly could probably be accounted for by more detailed investigation and greater diagnostic precision in the past decade resulting in more patients being recognised as having the disease. Nevertheless, the increase also occurred in people aged 55-65, albeit to a lesser extent, and it seems unlikely that the classic pattern of the disease would have been overlooked often in this age group in the 1970s. As the disease does not have a precise definition, however, small changes in diagnostic practice, irrespective of the intensity of any investigation, might be partly responsible for changes in reported mortality. The increase in the numbers of the elderly does not account for the rise in mortality as the age standardised mortality for each sex showed the same doubling as the absolute numbers of deaths. It is thus impossible to be certain how much of the rise is a real trend and how much is an artefact due to changes in diagnostic practice or classification and coding of the disease.
Using national mortality data we looked for factors associated with death from cryptogenic fibrosing alveolitis that might have an aetiological role. Firstly, we found that deaths from the disease were commoner in men at all ages (about 2 2: 1 overall). The disease has been found to be predominant among men in some2 12 but by no means all3' 1 surveys from specific centres. Why should this be? There are no clear genetic factors as, although familial fibrosing alveolitis has been described,'4 it is uncommon clinically and no definite link with any HLA pattern has been found." 16 Increased cigarette smoking is a potential factor in the higher mortality among men and needs further study; cigarette smoking was common (74-80%) in two studies of patients between 1950 and 1976.212 Male oriented sports and hobbies should be considered, but cryptogenic fibrosing alveolitis has numerous clinical differences from alveolitis due to extrinsic allergens. Occupational exposure to some factor, however, must be a strong contender, and support for this is provided by the regional differences found in this study, which, though small, suggest a concentration of the disease in the central industrialised areas of England and Wales. The data did not permit any further analysis of whether an urban or rural environment might be associated with mortality from the disease, though a report from Japan suggests that the disease might be commoner in rural areas.'7 Likewise, the numbers were too small to permit any analysis at subregional level.
The regional differences are unlikely to be due to differences in diagnostic practice as, if anything, fibrosing lung disease may be more likely to be labelled pneumoconiosis in industrial areas, though occupational chest radiographic screening is more common in these areas. If the regional differences do indeed reflect true differences in mortality then occupational exposure must be strongly considered to be a possible aetiological factor. This might be exposure to agents previously unrecognised as being fibrogenic or occult or low exposure to known agents, such as asbestos. In this respect we found no relation between the Registrar General's social class and mortality, suggesting that those working in manual occupations were not at increased risk; residual effects of mild exposure would nevertheless be difficult to identify.
The striking increase in mortality with age raises the additional possibility that the disease is a degenerative process in the lung. If this were the case, however, why, with its characteristic clinical pattern, was it not well described before the 1940s?8 Unless it was simply unrecognised among the much more common chronic chest diseases, notably tuberculosis, a long exposure to a fairly new environmental agent is again a likely explanation. Quite possibly, however, the disease is not aetiologically homogeneous and is a stereotyped response of the lung to various undetermined factors.
This study has shown for the first time that mortality from cryptogenic fibrosing alveolitis has doubled over the past 10 years, though some of this increase could be due to changes in diagnostic practice. The had fewer admissions, fewer psychiatric symptoms, and better social functioning and reported more satisfaction than the group treated in hospital. This study was replicated by Hoult and Reynolds in Sydney, Australia, with broadly similar findings,3 and they also found that patients and their relatives reported more satisfaction with the community treatment.4 Pai and Kapur examined home treatment for schizophrenic patients in Bangalore, India, and showed a reduction in family burden at six month follow up for those who had been treated at home.5 A number of earlier studies reported similar findings: the group treated at home had a better outcome." 8 Patients dependent on alcohol or drugs and those with organic brain syndromes have been excluded from all trials of home treatment. The older studies excluded patients without family or surrogate and those who were suicidal or homicidal. No study has shown that it is possible to avoid admission entirely. Grad and Sainsbury provided the only report of a total adult psychiatric service in Chichester, England, showing that an expansion in community facilities and increased domiciliary visiting by the psychiatric team greatly reduced the total number of admissions in comparison with the traditional service in Salisbury, which was demographically similar.9 None of the reported studies of home treatment were carried out in Great Britain and all were done 10-20 years ago, making it difficult to generalise the findings to current psychiatric practice in Britain.
We report a service in Birmingham that provides a total psychiatric service to a community by using home treatment principles. Central Birmingham psychiatric services are organised in sectors, with each general psychiatry consultant being responsible for patients under 65 in one or two electoral wards. CD is the consultant responsible for the inner city electoral ward of Sparkbrook, which has a population of 25 728 (1981 census). Over half the inhabitants are from the New Commonwealth or Pakistan, 11% from the Irish Republic, and 35% from the United Kingdom. The population is mostly social classes III manual, IV, or V; only 12% are in social class II or III non-manual of the Registrar General's classifications. Unemployment is
